Financials

  • Market Capitalization 416.57 M
  • Employee 71
  • Founded 2005
  • CEO N/A
  • Website www.larimartx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2NVH0
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
3.2
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3033
AVIR
Atea Pharmaceuticals, Inc. - common stock
5.33 USD-2.20%-2.56%+20.59%+66.04%427.49 M USD
3044
ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock
15.19 USD-6.06%+12.94%+164.17%-10.80%431.75 M USD
3061
GALT
Galectin Therapeutics Inc. - Common Stock
4.07 USD-1.69%+9.41%+18.66%-3.10%410.46 M USD
3075
XFOR
X4 Pharmaceuticals, Inc. - Common Stock
4.06 USD-4.02%0.00%+3.31%+36.70%402.54 M USD

Frequently asked questions about Larimar Therapeutics, Inc. Common Stock

What is the Larimar Therapeutics, Inc. Common Stock stock price today?

The current price of Larimar Therapeutics, Inc. Common Stock (LRMR) is 4.01. Over the past 24 hours, the stock has changed by -0.99%. Follow the LRMR chart for real-time price dynamics.

What is the stock ticker of Larimar Therapeutics, Inc. Common Stock?

Larimar Therapeutics, Inc. Common Stock trades under the ticker LRMR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Larimar Therapeutics, Inc. Common Stock stock going up?

LRMR has changed by -2.91% over the last week, +5.25% over the last month, and +2.30% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Larimar Therapeutics, Inc. Common Stock?

Larimar Therapeutics, Inc. Common Stock currently has a market capitalization of 416.57 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Larimar Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Larimar Therapeutics, Inc. Common Stock reported earnings of 3.01 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Larimar Therapeutics, Inc. Common Stock net income for the last quarter?

Larimar Therapeutics, Inc. Common Stock reported net income of -32.78 M for the last quarter. The previous quarter showed -29.61 M, which means net income changed by -10.70%.

How many employees does Larimar Therapeutics, Inc. Common Stock have?

As of the latest available data, Larimar Therapeutics, Inc. Common Stock has 71 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Larimar Therapeutics, Inc. Common Stock stock?

You can buy Larimar Therapeutics, Inc. Common Stock (LRMR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Larimar Therapeutics, Inc. Common Stock stock?

Investing in Larimar Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LRMR chart and related analysis on metatrader.com as part of your research.

News